conolidine - An Overview
These outcomes, together with a past report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 support the strategy of targeting ACKR3 as a novel approach to modulate the opioid process, which could open up new therapeutic avenues for opioid-connected disorders.Note: Success may perhaps vary about any pr